{"id":"https://openalex.org/W2154158706","doi":"https://doi.org/10.1124/jpet.108.141382","title":"N-Arachidonyl Maleimide Potentiates the Pharmacological and Biochemical Effects of the Endocannabinoid 2-Arachidonylglycerol through Inhibition of Monoacylglycerol Lipase","display_name":"N-Arachidonyl Maleimide Potentiates the Pharmacological and Biochemical Effects of the Endocannabinoid 2-Arachidonylglycerol through Inhibition of Monoacylglycerol Lipase","publication_year":2008,"publication_date":"2008-08-06","ids":{"openalex":"https://openalex.org/W2154158706","doi":"https://doi.org/10.1124/jpet.108.141382","mag":"2154158706","pmid":"https://pubmed.ncbi.nlm.nih.gov/18682568","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2605346"},"language":"en","primary_location":{"id":"doi:10.1124/jpet.108.141382","doi":"https://doi.org/10.1124/jpet.108.141382","is_oa":false,"landing_page_url":"https://doi.org/10.1124/jpet.108.141382","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2605346/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011572993","display_name":"James J. Burston","orcid":"https://orcid.org/0000-0001-6212-6870","observed_orcids":["https://orcid.org/0000-0001-6212-6870"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James J. Burston","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Virginia Commonwealth University, P.O. Box 980613, Richmond, VA 23298-0613, USA. jburston@vcu.edu","Department of Pharmacology and Toxicology, Virginia Commonwealth University, P.O. Box 980613, Richmond, VA 23298-0613 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, P.O. Box 980613, Richmond, VA 23298-0613, USA. jburston@vcu.edu","institution_ids":["https://openalex.org/I184840846"]},{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, P.O. Box 980613, Richmond, VA 23298-0613 USA","institution_ids":["https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060972778","display_name":"Laura J. Sim\u2010Selley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I178535277","display_name":"University of the West of England","ror":"https://ror.org/02nwg5t34","country_code":"GB","type":"education","lineage":["https://openalex.org/I178535277"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Laura J. Sim-Selley","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.J.B., L.J.S.-S., J.P.H., D.E.S., J.L.W.); Faculty of Applied Sciences, University of the West of England Bristol, Bristol, United Kingdom (J.J.B.); and Organix, Inc., Woburn, Massachusetts (A.M., R.K.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.J.B., L.J.S.-S., J.P.H., D.E.S., J.L.W.); Faculty of Applied Sciences, University of the West of England Bristol, Bristol, United Kingdom (J.J.B.); and Organix, Inc., Woburn, Massachusetts (A.M., R.K.R.)","institution_ids":["https://openalex.org/I178535277","https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068503013","display_name":"John P. Harloe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I178535277","display_name":"University of the West of England","ror":"https://ror.org/02nwg5t34","country_code":"GB","type":"education","lineage":["https://openalex.org/I178535277"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"John P. Harloe","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.J.B., L.J.S.-S., J.P.H., D.E.S., J.L.W.); Faculty of Applied Sciences, University of the West of England Bristol, Bristol, United Kingdom (J.J.B.); and Organix, Inc., Woburn, Massachusetts (A.M., R.K.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.J.B., L.J.S.-S., J.P.H., D.E.S., J.L.W.); Faculty of Applied Sciences, University of the West of England Bristol, Bristol, United Kingdom (J.J.B.); and Organix, Inc., Woburn, Massachusetts (A.M., R.K.R.)","institution_ids":["https://openalex.org/I178535277","https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021446398","display_name":"Anu Mahadevan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I178535277","display_name":"University of the West of England","ror":"https://ror.org/02nwg5t34","country_code":"GB","type":"education","lineage":["https://openalex.org/I178535277"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Anu Mahadevan","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.J.B., L.J.S.-S., J.P.H., D.E.S., J.L.W.); Faculty of Applied Sciences, University of the West of England Bristol, Bristol, United Kingdom (J.J.B.); and Organix, Inc., Woburn, Massachusetts (A.M., R.K.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.J.B., L.J.S.-S., J.P.H., D.E.S., J.L.W.); Faculty of Applied Sciences, University of the West of England Bristol, Bristol, United Kingdom (J.J.B.); and Organix, Inc., Woburn, Massachusetts (A.M., R.K.R.)","institution_ids":["https://openalex.org/I178535277","https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105886098","display_name":"Raj K. Razdan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I178535277","display_name":"University of the West of England","ror":"https://ror.org/02nwg5t34","country_code":"GB","type":"education","lineage":["https://openalex.org/I178535277"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Raj K. Razdan","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.J.B., L.J.S.-S., J.P.H., D.E.S., J.L.W.); Faculty of Applied Sciences, University of the West of England Bristol, Bristol, United Kingdom (J.J.B.); and Organix, Inc., Woburn, Massachusetts (A.M., R.K.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.J.B., L.J.S.-S., J.P.H., D.E.S., J.L.W.); Faculty of Applied Sciences, University of the West of England Bristol, Bristol, United Kingdom (J.J.B.); and Organix, Inc., Woburn, Massachusetts (A.M., R.K.R.)","institution_ids":["https://openalex.org/I178535277","https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010098064","display_name":"Dana E. Selley","orcid":"https://orcid.org/0000-0003-3118-9339","observed_orcids":["https://orcid.org/0000-0003-3118-9339"]},"institutions":[{"id":"https://openalex.org/I178535277","display_name":"University of the West of England","ror":"https://ror.org/02nwg5t34","country_code":"GB","type":"education","lineage":["https://openalex.org/I178535277"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Dana E. Selley","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.J.B., L.J.S.-S., J.P.H., D.E.S., J.L.W.); Faculty of Applied Sciences, University of the West of England Bristol, Bristol, United Kingdom (J.J.B.); and Organix, Inc., Woburn, Massachusetts (A.M., R.K.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.J.B., L.J.S.-S., J.P.H., D.E.S., J.L.W.); Faculty of Applied Sciences, University of the West of England Bristol, Bristol, United Kingdom (J.J.B.); and Organix, Inc., Woburn, Massachusetts (A.M., R.K.R.)","institution_ids":["https://openalex.org/I178535277","https://openalex.org/I184840846"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077728218","display_name":"Jenny L. Wiley","orcid":"https://orcid.org/0000-0001-8489-2947","observed_orcids":["https://orcid.org/0000-0001-8489-2947"]},"institutions":[{"id":"https://openalex.org/I178535277","display_name":"University of the West of England","ror":"https://ror.org/02nwg5t34","country_code":"GB","type":"education","lineage":["https://openalex.org/I178535277"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Jenny L. Wiley","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.J.B., L.J.S.-S., J.P.H., D.E.S., J.L.W.); Faculty of Applied Sciences, University of the West of England Bristol, Bristol, United Kingdom (J.J.B.); and Organix, Inc., Woburn, Massachusetts (A.M., R.K.R.)","Cntr Drug Discovery"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.J.B., L.J.S.-S., J.P.H., D.E.S., J.L.W.); Faculty of Applied Sciences, University of the West of England Bristol, Bristol, United Kingdom (J.J.B.); and Organix, Inc., Woburn, Massachusetts (A.M., R.K.R.)","institution_ids":["https://openalex.org/I178535277","https://openalex.org/I184840846"]},{"raw_affiliation_string":"Cntr Drug Discovery","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":4.2064,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.93149907,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"327","issue":"2","first_page":"546","last_page":"553"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoacylglycerol-lipase-inhibition","display_name":"monoacylglycerol lipase inhibition","score":0.9480000138282776},{"id":"https://openalex.org/keywords/2-arachidonoylglycerol","display_name":"2-arachidonoylglycerol","score":0.9369999766349792},{"id":"https://openalex.org/keywords/anandamide","display_name":"anandamide","score":0.9129999876022339},{"id":"https://openalex.org/keywords/endocannabinoid-system","display_name":"endocannabinoid system","score":0.9629999995231628},{"id":"https://openalex.org/keywords/cb1-receptor","display_name":"CB1 receptor","score":0.8349999785423279},{"id":"https://openalex.org/keywords/cb2-receptor","display_name":"CB2 receptor","score":0.5809999704360962},{"id":"https://openalex.org/keywords/g-protein-activation","display_name":"G protein activation","score":0.7120000123977661},{"id":"https://openalex.org/keywords/hypothermia","display_name":"hypothermia","score":0.7200000286102295},{"id":"https://openalex.org/keywords/catalepsy","display_name":"catalepsy","score":0.9980000257492065},{"id":"https://openalex.org/keywords/delta9-tetrahydrocannabinol","display_name":"delta-9-tetrahydrocannabinol","score":0.8159999847412109}],"concepts":[{"id":"https://openalex.org/C8051207","wikidata":"https://www.wikidata.org/wiki/Q4678003","display_name":"Monoacylglycerol lipase","level":4,"score":0.9657745361328125},{"id":"https://openalex.org/C2781144285","wikidata":"https://www.wikidata.org/wiki/Q21113274","display_name":"Fatty acid amide hydrolase","level":5,"score":0.8747998476028442},{"id":"https://openalex.org/C46721173","wikidata":"https://www.wikidata.org/wiki/Q368952","display_name":"Endocannabinoid system","level":3,"score":0.8178340196609497},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.788001298904419},{"id":"https://openalex.org/C2779783865","wikidata":"https://www.wikidata.org/wiki/Q410228","display_name":"Anandamide","level":5,"score":0.7657668590545654},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5278140306472778},{"id":"https://openalex.org/C148001335","wikidata":"https://www.wikidata.org/wiki/Q421237","display_name":"Cannabinoid receptor","level":4,"score":0.4789629280567169},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.47244793176651},{"id":"https://openalex.org/C2780871563","wikidata":"https://www.wikidata.org/wiki/Q422936","display_name":"Cannabinoid","level":3,"score":0.46977323293685913},{"id":"https://openalex.org/C2780902120","wikidata":"https://www.wikidata.org/wiki/Q21102593","display_name":"Diacylglycerol lipase","level":5,"score":0.45162880420684814},{"id":"https://openalex.org/C2776749334","wikidata":"https://www.wikidata.org/wiki/Q907219","display_name":"Tiagabine","level":4,"score":0.42666661739349365},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3989681899547577},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.38506072759628296},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.1761377453804016},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15154072642326355},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09594351053237915},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.07258248329162598},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077285","descriptor_name":"Rimonabant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001095","descriptor_name":"Arachidonic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005989","descriptor_name":"Glycerides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008301","descriptor_name":"Maleimides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008994","descriptor_name":"Monoacylglycerol Lipases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016244","descriptor_name":"Guanosine 5'-O-(3-Thiotriphosphate)","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D043884","descriptor_name":"Receptor, Cannabinoid, CB1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D043884","descriptor_name":"Receptor, Cannabinoid, CB1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D063388","descriptor_name":"Endocannabinoids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1124/jpet.108.141382","doi":"https://doi.org/10.1124/jpet.108.141382","is_oa":false,"landing_page_url":"https://doi.org/10.1124/jpet.108.141382","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:18682568","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18682568","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2605346","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2605346/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Pharmacol Exp Ther","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.994.873","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.994.873","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jpet.aspetjournals.org/content/327/2/546.full.pdf","raw_type":"text"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:112078","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/112078/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2605346","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2605346/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Pharmacol Exp Ther","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1639573605","display_name":"THC RECEPTORS","funder_award_id":"R37DA003672","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G1666262111","display_name":null,"funder_award_id":"DA-05488","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G2529979218","display_name":"Endogenous Cannabinoids and Brain Function","funder_award_id":"P01DA009789","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G287263546","display_name":"Brain Cannabinoid Signaling: Selectivity and Adaptation","funder_award_id":"R01DA014277","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G292588079","display_name":null,"funder_award_id":"DA 05274","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G3835323716","display_name":null,"funder_award_id":"DA\u201003672","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G3861330550","display_name":"Sex Differences in Cannabinoid Dependence and Analgesia","funder_award_id":"R01DA016644","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G723894345","display_name":"Investigation of THC Receptors","funder_award_id":"R01DA003672","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G7485604392","display_name":"Synthesis of delta9-Tetrahydrocannabinol Related Compounds","funder_award_id":"R01DA005488","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G8988406653","display_name":"CENTER FOR DRUG ABUSE RESEARCH","funder_award_id":"P50DA005274","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W93427742","https://openalex.org/W1485798291","https://openalex.org/W1491261527","https://openalex.org/W1545427561","https://openalex.org/W1819429514","https://openalex.org/W1911828734","https://openalex.org/W1921386713","https://openalex.org/W1931308193","https://openalex.org/W1955332844","https://openalex.org/W1966469041","https://openalex.org/W1975317880","https://openalex.org/W1989073099","https://openalex.org/W1991461690","https://openalex.org/W2004531640","https://openalex.org/W2006280591","https://openalex.org/W2009968727","https://openalex.org/W2015614945","https://openalex.org/W2030777873","https://openalex.org/W2032715817","https://openalex.org/W2036000997","https://openalex.org/W2036248385","https://openalex.org/W2044535743","https://openalex.org/W2050302477","https://openalex.org/W2057779865","https://openalex.org/W2059254350","https://openalex.org/W2061301719","https://openalex.org/W2068903408","https://openalex.org/W2072168992","https://openalex.org/W2074698946","https://openalex.org/W2079819783","https://openalex.org/W2093775315","https://openalex.org/W2094468554","https://openalex.org/W2124248227","https://openalex.org/W2128635872","https://openalex.org/W2139261360","https://openalex.org/W2141753787","https://openalex.org/W2157400187","https://openalex.org/W2164035198","https://openalex.org/W4241363254"],"related_works":["https://openalex.org/W7096495777","https://openalex.org/W1738452423","https://openalex.org/W2106136739","https://openalex.org/W7097695362","https://openalex.org/W2051554315","https://openalex.org/W2043446105","https://openalex.org/W2128615732","https://openalex.org/W1998058095","https://openalex.org/W7099461628","https://openalex.org/W2031325755"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}